Over the past five years, Barry served as the CEO of Nuvasive, a spine specialist company, which was acquired by the orthopedic company Globus Medical in September. Prior to his tenure at Nuvasive, Barry held leadership positions at Medtronic and Covidien.
In March, Barry will join 3M to lead its Medical Solutions Division, encompassing wound care products. His responsibilities include driving growth for the division, portfolio management, and innovation in both business models and products.
Barry is the latest addition to the roster of medtech executives joining 3M’s healthcare business as the company prepares for a spinoff. 3M has also recruited executives from Zimmer Biomet and Insulet to lead the new company, named Solventum.
The company’s spinoff is anticipated to take place in the first half of 2024, pending board approval and other conditions.